Key result
APOA4 infusion reduces hepatic lipids and improves glucose tolerance in old but not young mice.
Why the study?
Aging is associated with decreased hepatic fatty acid oxidation, impaired glucose tolerance, and reduced APOA4 levels, leading to the hypothesis that APOA4 improves age-related glucose homeostasis.
Does Apolipoprotein A4 infusion improve glucose homeostasis and reduce hepatic lipid accumulation in aging mice?
Does Apolipoprotein A4 infusion improve glucose homeostasis and reduce hepatic lipid accumulation in aging mice?
Answers are grounded in this paper and cite their sources.
APOA4 infusion improves aging-related glucose homeostasis and reduces hepatic lipid accumulation in old mice, suggesting a potential therapeutic role in age-related metabolic decline.
Introduction and Objective: Aging is associated with a decline in hepatic fatty acid oxidation, leading to increased hepatic lipid accumulation, impaired glucose tolerance, and a higher risk of age-related type 2 diabetes. Apolipoprotein A4 (APOA4) has been shown to attenuate high-fat diet-induced hepatic lipid accumulation and improve glucose tolerance. Our preliminary data show that old mice exhibit lower plasma APOA4 levels. We hypothesized that APOA4 would reduce age-related hepatic lipid accumulation by enhancing fatty acid oxidation and improving glucose homeostasis. Methods: To test this, male mice fed a chow diet received a 4-week infusion of either saline or APOA4 at a physiological dose. Hepatic fatty acid oxidation, hepatic lipid accumulation, and glucose tolerance were assessed in both young and old mice with or without APOA4 treatment. Results: APOA4 infusion increased hepatic fatty acid oxidation, reduced liver weight and hepatic lipid accumulation, and improved glucose tolerance in old mice, but not in young mice. Conclusion: In conclusion, maintaining APOA4 level enhances hepatic fatty acid oxidation, decreases hepatic lipid accumulation, and promotes glucose tolerance during aging.
No takes yet. Share an insight, caveat, or question.
Bashir et al. (2026) studied Aging-related glucose homeostasis and hepatic lipid accumulation. Apolipoprotein A4 (APOA4) vs. Saline was evaluated on Hepatic fatty acid oxidation, hepatic lipid accumulation, and glucose tolerance. A 4-week infusion of APOA4 increased hepatic fatty acid oxidation, reduced liver weight and hepatic lipid accumulation, and improved glucose tolerance in old male mice, but not in young mice.
Synapse has enriched 10 related papers. Consider them for comparative context: